My First Step Into the Pulmonary Circulation World

28 December 2025

Norbert F. Voelkel

https://doi.org/10.1002/pul2.70193 

 

I graduated from the University of Hamburg Faculty of Medicine in 1972. In 1973, as a second-year resident in Internal Medicine at the University Hospital in Hamburg-Eppendorf, I experienced a night on call that remains vivid in my memory.

My pager sounded in the middle of a warm June night—about two o'clock in the morning. In those days, there were no direct communication pagers; the call came through the telephone central, and the operator informed me that I was needed on the Cardiology floor. As I rode the elevator to the 8th floor, my mind raced through possible emergencies: acute chest pain, a dangerous arrhythmia, or acute heart failure. The ward was dark, except for the softly lit nurses' station.

I introduced myself to the night nurse, who apologized, “I'm sorry to have to call you, but I need you to pronounce a patient dead. She just passed away a few minutes ago.” I entered the room and found a young woman, pulseless and still. The quiet in the room was striking. The nurse gave me the time of death, and I signed the certificate—sudden death of a young woman on the Cardiology ward. All that remained was to read her medical record.

The diagnosis was primary pulmonary hypertension, caused by the appetite suppressant Menocil (aminorex), an amphetamine derivative prescribed in Germany, Austria, and Switzerland in 1969 and 1970. The drug had been withdrawn in 1971 after it was discovered that the incidence of primary pulmonary hypertension had increased a thousand-fold, with aminorex as the common factor. According to her record, the patient had taken the drug after her second pregnancy, hoping to fit into her bikini again.

Read the full historical vignette

Share: